HIV-1 Rebound Virus Consists of a Small Number of Lineages That Entered the Reservoir Close to ART Initiation
Tyers, L.; Ntuli, J.; Moeser, M.; Council, O.; Zhou, S.; Spielvogel, E.; Sondgeroth, A.; Adams, C.; Thebus, R.; Yssel, A.; Karim, S. A.; Garrett, N.; Pond, S. K.; Williamson, C.; Swanstrom, R.; Abrahams, M.-R.; Joseph, S. B.
Show abstract
HIV-1 persists as a latent reservoir during suppressive antiretroviral therapy (ART). Viral rebound occurs upon ART interruption, posing a challenge to cure efforts. Characterizing viral populations fuelling rebound is imperative to curing HIV-1. We used longitudinal samples collected pretherapy from women in the CAPRISA 002 cohort to create an evolutionary time- line to determine the pretherapy timepoint when the rebound virus originally entered the long- lived reservoir. Participants (N=10) were untreated for an average of 5 years then on ART for an average of 2 years before viral rebound (defined as >1000 RNA copies/ml). env sequences were used to characterize the longitudinal pre-ART evolving viral RNA population, the proviral DNA reservoir during ART, and viral RNA in the plasma during rebound. For each participant, between 1 and 3 major viral lineages were identified in the plasma during rebound. A total of 20 rebound virus lineages were examined for the 10 participants, and 19 were found to have entered the reservoir around the time of therapy initiation. The one lineage estimated to enter the reservoir more than a year before therapy was observed in a participant who was untreated for more than 8 years, yet retained moderate CD4 T cell counts. Analysis of the viral DNA reservoir, from which the rebound viruses emanated, revealed that while 95% of rebounding lineages dated to the year before ART initiation, only 61% of unique proviruses dated to that time period. Strikingly, for three participants with DNA reservoirs dominated by viruses from earlier in untreated infection, only 33% of unique proviruses dated to the year before ART initiation, yet 83% of rebounding lineages dated to that time. Our results show that rebound virus almost exclusively comes from the portion of the latent reservoir that formed around the time of therapy initiation, even when the reservoir is composed of diverse sequences from across the pre-ART time period. Author SummaryHIV-1 is maintained in a long-lived reservoir during suppressive therapy. Virus rebounds if therapy is discontinued. We found that in most cases rebound virus comes from a pool of viral sequences that entered the long-lived reservoir around the time of therapy initiation. While the viral DNA reservoir is on average also skewed toward sequences replicating around the time of therapy initiation, the rebound virus almost exclusively comes from this portion of the latent reservoir, even when the reservoir contained proviruses from much earlier in untreated infection. Thus, we hypothesize that there are features of the viruses forming the latent reservoir around the time of therapy initiation, or features of the host at that time, that select these viruses as initiators of rebound during therapy discontinuation.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Mutations that confer resistance to broadly-neutralizing antibodies define HIV-1 variants of transmitting mothers from that of non-transmitting mothers 97%
- The Interferon Resistance of Transmitted HIV-1 is a Consequence of Enhanced Replicative Fitness 95%
- Genetic variation of the HIV-1 subtype C transmitted/founder viruses long terminal repeat elements and the impact on transcription activation potential and clinical disease outcomes 95%
Similar papers in this journal
- The role of Nef in the long-term persistence of the replication-competent HIV reservoir in South African women 97%
- Vertical HIV-1 transmission in the setting of maternal broad and potent antibody responses 95%
- Sequence evaluation and comparative analysis of novel assays for intact proviral HIV-1 DNA 95%
Similar papers in this journal
- Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size 96%
- No Evidence that Ongoing HIV-Specific Immune Responses Contribute to Persistent Inflammation and Immune Activation in Persons on Long-Term ART 95%
- Associations of functional HLA class I groups with HIV viral load in a heterogeneous cohort 94%
Similar papers in this journal
- Differential HIV-1 Proviral Defects in Children vs. Adults on Antiretroviral Therapy 97%
- HIV-1 envelope glycoproteins proteolytic cleavage protects infected cells from ADCC mediated by plasma from infected individuals 94%
- QuickFit: A high-throughput RT-qPCR-based assay to quantify viral growth and fitness in vitro 94%
Similar papers in this journal
- Deficient uracil base excision repair leads to persistent dUMP in HIV proviruses during infection of monocytes and macrophages 95%
- Brief report: Mutations in SIV Nef that disrupt and restore tetherin downregulation 95%
- Virologic outcomes on dolutegravir-, atazanavir-, or efavirenz-based ART in urban Zimbabwe: A longitudinal study 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.